Rifamycin SV

Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.

Cross Reference

Introduction

To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Rifamycin SV?

Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Rifamycin SV

MeSH term MeSH ID Detail
Diarrhea D003967 32 associated lipids
Pain D010146 64 associated lipids
Abscess D000038 13 associated lipids
Fractures, Spontaneous D005598 4 associated lipids
Osteomyelitis D010019 10 associated lipids
Alzheimer Disease D000544 76 associated lipids
Intraoperative Complications D007431 5 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Anaphylaxis D000707 35 associated lipids
Per page 10 20 | Total 18

PubChem Associated disorders and diseases

What pathways are associated with Rifamycin SV

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Rifamycin SV?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Rifamycin SV?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

What genes are associated with Rifamycin SV?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Rifamycin SV?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Rifamycin SV

Download all related citations
Per page 10 20 50 100 | Total 175
Authors Title Published Journal PubMed Link
pmid:
Bi YA et al. Reliable Rate Measurements for Active and Passive Hepatic Uptake Using Plated Human Hepatocytes. 2017 AAPS J pmid:28188574
Peng WT et al. Bacterial type I glutamine synthetase of the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32, is the only enzyme responsible for glutamine synthesis under physiological conditions. 2006 Acta Biochim. Biophys. Sin. (Shanghai) pmid:17151776
Yu H et al. Identification and characterization of glnA promoter and its corresponding trans-regulatory protein GlnR in the rifamycin SV producing actinomycete, Amycolatopsis mediterranei U32. 2006 Acta Biochim. Biophys. Sin. (Shanghai) pmid:17151777
Zhang Y et al. GlnR positive transcriptional regulation of the phosphate-specific transport system pstSCAB in Amycolatopsis mediterranei U32. 2018 Acta Biochim. Biophys. Sin. (Shanghai) pmid:30007316
Yuan H et al. Two genes, rif15 and rif16, of the rifamycin biosynthetic gene cluster in Amycolatopsis mediterranei likely encode a transketolase and a P450 monooxygenase, respectively, both essential for the conversion of rifamycin SV into B. 2011 Acta Biochim. Biophys. Sin. (Shanghai) pmid:21986914
Kawde AN et al. Adsorptive stripping voltammetry of antibiotics rifamycin SV and rifampicin at renewable pencil electrodes. 2014 Acta Chim Slov pmid:25125124
González CI et al. Reverse transcriptase-like activity in Trypanosoma cruzi. 1997 Acta Trop. pmid:9088425
Singh R et al. No impact of rifamycin selection on tuberculosis treatment outcome in HIV coinfected patients. 2013 AIDS pmid:23014518
Antonicelli L et al. IgE-mediated reactions to rifaximin and rifamycin SV and cross-reactivity among rifamycins. 2009 Allergy pmid:19416136
Craven N and Anderson JC Antibiotic activity against intraleukocytic Staphylococcus aureus in vitro and in experimental mastitis in mice. 1983 Am. J. Vet. Res. pmid:6553464
Iselin F et al. [Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery]. 1990 Ann Chir Main Memb Super pmid:2346354
Revuz J et al. [Generalization of zona in a nonimmunosuppressed patient receiving isoprinosine and rifamycin SV]. 1983 Ann Dermatol Venereol pmid:6195953
Hanzlik J et al. [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"]. 1986 Ann Univ Mariae Curie Sklodowska Med pmid:3154057
Erel F et al. Severe anaphylaxis from rifamycin SV. 1998 Ann. Allergy Asthma Immunol. pmid:9759804
Caruso I et al. Rheumatoid knee synovitis successfully treated with intra-articular rifamycin SV. 1982 Ann. Rheum. Dis. pmid:7046652
Maggi N et al. New derivatives of rifamycin SV. 1965 Antimicrob Agents Chemother (Bethesda) pmid:4956802
Kradolfer F et al. Chemotherapeutic activity of new derivatives of rifamycin. 1966 Antimicrob Agents Chemother (Bethesda) pmid:5985258
Farrell DJ et al. In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficile. 2011 Antimicrob. Agents Chemother. pmid:21149623
Di Stefano AF et al. Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers. 2011 Antimicrob. Agents Chemother. pmid:21402860
Mariner KR et al. Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. 2010 Antimicrob. Agents Chemother. pmid:20660693
KLUEPFEL D et al. METABOLISM OF BARBITAL BY STREPTOMYCES MEDITERRANEI. 1965 Appl Microbiol pmid:14339268
MARGALITH P and PAGANI H Rifomycin. XIV. Production of rifomycin B. 1961 Appl Microbiol pmid:13766661
THIEMANN JE et al. RIFAMYCIN. XXXIV. PHYSICOCHEMICAL CHARACTERIZATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI. 1964 Appl Microbiol pmid:14170965
THIEMANN JE et al. RIFAMYCIN. XXXIII. ISOLATION OF ACTINOPHAGES ACTIVE ON STREPTOMYCES MEDITERRANEI AND CHARACTERISTICS OF PHAGE-RESISTANT STRAINS. 1964 Appl Microbiol pmid:14167333
MARGALITH P and PAGANI H Rifomycin. XIII. Fermentation and production of rifomycin complex. 1961 Appl Microbiol pmid:13766660
Zhang W et al. Molecular analysis and heterologous expression of the gene encoding methylmalonyl-coenzyme A mutase from rifamycin SV-producing strain Amycolatopsis mediterranei U32. 1999 Appl. Biochem. Biotechnol. pmid:10813025
Wang W et al. MoeA, an enzyme in the molybdopterin synthesis pathway, is required for rifamycin SV production in Amycolatopsis mediterranei U32. 2002 Appl. Microbiol. Biotechnol. pmid:12382055
Nagavalli M et al. Enhanced rifamycin SV production by submerged fermentation using Amycolatopsis mediterranei. 2015 Appl. Microbiol. Biotechnol. pmid:26026938
Kukiełka E and Cederbaum AI Stimulation of microsomal production of reactive oxygen intermediates by rifamycin SV: effect of ferric complexes and comparisons between NADPH and NADH. 1992 Arch. Biochem. Biophys. pmid:1329662
Wang W et al. Molecular and biochemical characterization of a novel two-component signal transduction system, amrA- amkA, involved in rifamycin SV production in Amycolatopsis mediterranei U32. 2002 Arch. Microbiol. pmid:12375106
Shao Z et al. Identification and functional analysis of a nitrate assimilation operon nasACKBDEF from Amycolatopsis mediterranei U32. 2011 Arch. Microbiol. pmid:21424691
Yu H et al. A complex role of Amycolatopsis mediterranei GlnR in nitrogen metabolism and related antibiotics production. 2007 Arch. Microbiol. pmid:17364194
Magdalan J et al. Comparative antidotal efficacy of benzylpenicillin, ceftazidime and rifamycin in cultured human hepatocytes intoxicated with α-amanitin. 2009 Arch. Toxicol. pmid:19730819
Yang L et al. An eukaryotic-type serine/threonine protein kinase involved in the carbon source-dependent pigment biosynthesis in Amycolatopsis mediterranei U32. 2001 Biochem. Biophys. Res. Commun. pmid:11394886
Kukiełka E and Cederbaum AI Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV. 1995 Biochem. J. pmid:7733870
Quinlan GJ and Gutteridge JM DNA base damage by beta-lactam, tetracycline, bacitracin and rifamycin antibacterial antibiotics. 1991 Biochem. Pharmacol. pmid:1930286
Eichler HG et al. Studies on the uptake of low molecular weight monomeric tris-galactosyl conjugates by the rat liver. 1992 Biochem. Pharmacol. pmid:1472076
Quinlan GJ and Gutteridge JM Oxygen radical damage to DNA by rifamycin SV and copper ions. 1987 Biochem. Pharmacol. pmid:2823829
Fardel O et al. Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells. 1995 Biochem. Pharmacol. pmid:7763306
Sáez GT et al. Effect of metal ion catalyzed oxidation of rifamycin SV on cell viability and metabolic performance of isolated rat hepatocytes. 1991 Biochim. Biophys. Acta pmid:2049402
Passamonti S and Sottocasa GL The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. 1988 Biochim. Biophys. Acta pmid:3401473
Chernov AP et al. Recombinant reverse transcriptase of Rous sarcoma virus: characterization of DNA polymerase and RNAase H activities. 1991 Biomed. Sci. pmid:1717011
Deshko TN et al. [Physico-chemical properties of DNA-dependent RNA-polymerase from Escherichia coli and its subunits]. 1984 Bioorg. Khim. pmid:6388581
Li J et al. Preparation and in vitro anti-staphylococcal activity of novel 11-deoxy-11-hydroxyiminorifamycins. 2007 Bioorg. Med. Chem. Lett. pmid:17826091
Kumar S et al. Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. 2013 Bioorg. Med. Chem. Lett. pmid:23474387
Knight JL et al. Distance-restrained docking of rifampicin and rifamycin SV to RNA polymerase using systematic FRET measurements: developing benchmarks of model quality and reliability. 2005 Biophys. J. pmid:15542547
Krishna PS et al. Biosynthesis of rifamycin SV by Amycolatopsis mediterranei MTCC17 in solid cultures. 2003 Biotechnol. Appl. Biochem. pmid:12546705
Chen L et al. Cloning and preliminary characterization of lh3 gene encoding a putative acetyltransferase from a rifamycin SV-producing strain Amycolatopsis mediterranei. 2005 Biotechnol. Lett. pmid:16132864
Chiao JS et al. Rifamycin SV and related ansamycins. 1995 Biotechnology pmid:8688635